{
    "2019-03-14": [
        [
            {
                "time": "2018-03-14",
                "original_text": "格隆汇港股聚焦(3.14)︱旭辉控股集团2018年度核心净利润升35.6%至55.36亿元 末期息19.68分",
                "features": {
                    "keywords": [
                        "旭辉控股",
                        "净利润",
                        "增长",
                        "35.6%",
                        "分红"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "房地产"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-14",
                "original_text": "上海医药计提三家子公司商誉减值 预计净利润减少近5亿元 盈利能力下降",
                "features": {
                    "keywords": [
                        "上海医药",
                        "商誉减值",
                        "净利润减少",
                        "5亿元",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-14",
                "original_text": "3月14日上市公司晚间公告速递",
                "features": {
                    "keywords": [
                        "公告速递",
                        "上市公司"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-14",
                "original_text": "上海医药：计提超6亿元商誉减值准备 资产异常",
                "features": {
                    "keywords": [
                        "上海医药",
                        "商誉减值",
                        "6亿元",
                        "资产异常"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-14",
                "original_text": "上海医药：计提商誉减值准备6.32亿元",
                "features": {
                    "keywords": [
                        "上海医药",
                        "商誉减值",
                        "6.32亿元"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-14",
                "original_text": "[中性评级]兴证海外医药周报：创新驱动成长 制造降税减负",
                "features": {
                    "keywords": [
                        "医药",
                        "创新",
                        "驱动",
                        "成长",
                        "降税减负"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-14",
                "original_text": "沾上“大麻”龙津药业股价飞天 周四公司高管坐阵全景网集体答疑",
                "features": {
                    "keywords": [
                        "龙津药业",
                        "大麻",
                        "股价飞天",
                        "高管答疑"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}